Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.4 USD | -1.45% | -9.09% | -6.85% |
May. 14 | Sector Update: Health Care Stocks Steady Premarket Tuesday | MT |
May. 14 | HealthEquity Completes Acquisition of Conduent's BenefitWallet | MT |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- The company has a low valuation given the cash flows generated by its activity.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- For several months, analysts have been revising their EPS estimates roughly upwards.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company's earnings growth outlook lacks momentum and is a weakness.
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company has insufficient levels of profitability.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: IT Services & Consulting
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-6.85% | 706M | B | ||
+4.19% | 35.89B | B+ | ||
-0.38% | 15.29B | C- | ||
-5.59% | 9.48B | B | ||
+2.00% | 7.2B | C | ||
+15.06% | 5.57B | B+ | ||
-49.66% | 4.29B | - | - | |
+7.54% | 2.92B | D | ||
-19.77% | 2.21B | - | C | |
-6.73% | 2.11B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CNDT Stock
- Ratings Conduent Incorporated